Committee for Orphan Medicinal Products (COMP): 14-16 February 2017
EventHumanRare diseases
Date
Location
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
COMP meeting report on the review of applications for orphan designation: February 2017
Agenda - COMP agenda of the 14-16 February 2017 meeting
Minutes of the COMP meeting 14-16 February 2017